Recently, Medtronic, the world's largest independent medical device company, officially settled in Chengdu. Its world's first innovative hemodialysis system development and production project was officially launched, with an investment of 70 million US dollars. It was officially put into operation in 2016. According to Medtronic China, the company will build the first multinational medical device manufacturing base in Chengdu in the future. It is understood that Medtronic’s intention is to establish a global market based on the chronic disease market of 110 million people in China. At present, Medtronic's annual revenue is about 17 billion US dollars. It is the world's largest independent medical device company, and its products are applied in major chronic diseases such as heart disease, vascular system, diabetes and orthopedic diseases. The innovative hemodialysis system that was launched in Chengdu is mainly used for the treatment of end-stage renal disease, and is a new breakthrough in Medtronic's innovative therapy field. "In the near future, Medtronic Hemodiatic products, which are labeled in Chengdu, will be sold to China and around the world to serve patients with end-stage renal disease," said Omar Ishrak, Chairman and CEO of Medtronic. Perhaps completing the above-mentioned market tasks is accompanied by Medtronic's supportive global expansion strategy based on China's 110 million patients with chronic kidney disease. It is understood that the current traditional hemodialysis cost is high, the construction of hemodialysis facilities, maintenance costs, land occupation, water consumption requirements are relatively high. In large hospitals that offer this therapy, the hemodialysis center is mostly overcrowded and overloaded. In addition, the lack of professional hemodialysis personnel, resulting in slow development of hemodialysis in China. Taking the current Chinese patients as an example, there are about 110 million patients with chronic kidney disease in the country, of which 1.5 million to 2 million are in the end stage, and only 300,000 of them have the opportunity to receive hemodialysis. According to statistics from relevant departments, the number of patients with end-stage renal disease will rise to 3 million by 2025. And Medtronic's innovative hemodialysis system has low cost of hospital supporting infrastructure and treatment, low water consumption, low dependence on professionals, and is suitable for small and medium-sized hospitals, primary health institutions and even families. According to Li Xilie, president of Medtronic Greater China, he will now make an example in Chengdu and gradually push it to the whole country. Omar Ishrak said that the future innovation of hemodialysis products will lead to a significant cost reduction. At present, the cost of a single hemodialysis for patients is 300 to 400 RMB. Perhaps this is a boon for patients with kidney disease. Chengdu is also an important medical service center in the country. Chengdu Hi-tech Zone has formed a global leading drug development platform and 21 biomedical public technology platforms such as the internationally renowned drug safety evaluation center. Last year's bio-industry output value was 8.19 billion yuan.
B/W Ultrasound Scanner,B/W Full Digital Ultrasound Scanner,Portable B/W Ultrasound Scanner,Wireless Ultrasound Scanner
Professional B/W Ultrasound Scanner manufacturer is located in China, including B/W Full Digital Ultrasound Scanner,Portable B/W Ultrasound Scanner,Wireless Ultrasound Scanner, etc.
Clinical value B/W Ultrasound Scanner,B/W Full Digital Ultrasound Scanner,Portable B/W Ultrasound Scanner,Wireless Ultrasound Scanner Guangzhou Sonostar Technologies Co., Limited , https://www.sonoeye.com
Precision medicalvisualization tool, first aid quick examination, basic examination, wireless ultrasound probe is not only help the medical workers to improve working efficiency, reduce labor intensity and working pressure, but also improve diagnostic confidence and treatment.Minimize diagnostic and treatment errors, complications, sequelae, medical accidents and disputes
Application directions
1. Visualization tools: invasive intervention guide, surgical and therapy guidance.
2. Emergency inspection: ER, ICU, Wild First Aid, battlefieldrescue.
3. Preliminary examination: Ward Inspection, primary clinicexamination medical examination, health screening,home care, family planning, etc.
4. Remote diagnosis, consultation, training: works on smart phone or tablet, easy telecommunications.
Applicable Clinic
Anaesthesia, pain, ICU, urology, nephrology, cardiology, rehabilitation, orthopedics, gynaecology, reproductive, obstetrics, neonatology, pneumology, gastroenterology, hepatological surgery, general surgery, vascular surgery, thyroid surgery, skull surgery, neurology, transplantation, ophthalmology, dermatology, emergency, nursing, inpatient, physical examination, and ER ambulance, primary care, family planning centers, family medicine, home care, nursing home, prisons, plastic surgery, small needle knife/acupuncture treatment clinic, sports medicine, battle field ambulance, disaster ambulance, etc.
Example of usages
Puncture/intervention guide: thyroid ablation, neck vein puncture, subclavian vein puncture, and neck and arm nerves, canal of arantius, spine puncture, radial vein injection, percutaneous renal surgery guide, hemodialysis catheter/thrombosis monitoring, abortion, bile duct puncture, hydropsarticuli extraction, pain therapy and cosmetic surgery, urine catheterization. Emergency inspection:internal bleeding, Pleural effusion, pneumothorax, Atelectasis of lung, Temporal / posterior auricular fistula, pericardial effusion. Daily inspection:thyroid, breast, liver cirrhosis, fatty liver, prostate/pelvics, stroke screening, retinal artery, uterus, follicular monitoring, fetus, musculoskeletal, podiatry, fractures, varicose veins, spleen, bladder/urinary function, urine volume measurement.